Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Alpelisib's trials
EPIK-RO
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Alpelisib
Ongoing
Not yet recruiting
Phase 2
Open NCT07679269 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
EPIK-RO · Trial Tracker · ComplyRx
